Last €23.67 EUR
Change Today +0.30 / 1.28%
Volume 25.2K
PFE On Other Exchanges
Symbol
Exchange
New York
Xetra
Mexico
SIX Swiss Ex
Stockholm
London
Sao Paulo
Bogota
As of 1:50 PM 09/18/14 All times are local (Market data is delayed by at least 15 minutes).

pfizer inc (PFE) Snapshot

Open
€23.62
Previous Close
€23.37
Day High
€23.79
Day Low
€23.51
52 Week High
11/25/13 - €24.08
52 Week Low
08/8/14 - €20.69
Market Cap
150.1B
Average Volume 10 Days
13.2K
EPS TTM
--
Shares Outstanding
6.3B
EX-Date
07/30/14
P/E TM
--
Dividend
€1.00
Dividend Yield
3.17%
Current Stock Chart for PFIZER INC (PFE)

pfizer inc (PFE) Details

Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines, and various consumer healthcare products. The company’s Primary Care segment offers prescription pharmaceutical products primarily prescribed by primary-care physicians for various therapeutic and disease areas comprising Alzheimer’s disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation. Its Specialty Care and Oncology segment provides prescription pharmaceutical products for anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines, as well as oncology and oncology-related illnesses. The company’s Established Products and Emerging Markets segment offers prescription pharmaceutical products that had lost patent protection or marketing exclusivity in certain countries and/or regions, as well as sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. Its Consumer Healthcare segment provides non-prescription products in a range of therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company also offers Lyrica, the Prevnar family of products, Enbrel, Celebrex, Lipitor, Viagra, Zyvox, Norvasc, Sutent, and the Premarin family of products; and consumer healthcare products under the Advil, Caltrate, Centrum, ChapStick, Emergen-C, Preparation H, and Robitussin brands. It serves wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, and grocery and convenience stores. It has strategic alliance with CliniWorks (Israel) Ltd. to develop population health management platform with advanced analytics and patient care capabilities. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

77,700 Employees
Last Reported Date: 02/28/14
Founded in 1849

pfizer inc (PFE) Top Compensated Officers

Chairman, Chief Executive Officer and Chairma...
Total Annual Compensation: $1.8M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $1.2M
President of Worldwide Research and Developme...
Total Annual Compensation: $1.1M
Group President of Global Innovative Pharma B...
Total Annual Compensation: $926.3K
Group President of Global Established Pharma ...
Total Annual Compensation: $810.1K
Compensation as of Fiscal Year 2013.

pfizer inc (PFE) Key Developments

Pfizer Inc. Seeks Acquisitions

Pfizer Inc. (NYSE:PFE) is looking at big, medium and small acquisitions, anything that fits with its current strategy to support innovative businesses, the established business and helps in growth of the company.

Pfizer Inc. Presents at The Economist Health Care Forum, Sep-17-2014 09:45 AM

Pfizer Inc. Presents at The Economist Health Care Forum, Sep-17-2014 09:45 AM. Venue: Seaport Boston Hotel, 1 Seaport Lane, Boston, MA 02210, United States. Speakers: Albert Bourla, Group President of the Vaccines, Oncology and Consumer Healthcare Business.

Pfizer to Invest $5.4 Million in Romanian Drug Plant; Plans to Transfer Part of the Production in Soborg and Aprilia

Pfizer announced it is investing $5.4 million (EUR 4.1 million) in the packaging line of its Ferrosan plant in the northwestern Romanian city of Cluj-Napoca. The company also plans to transfer part of the production in Soborg and Aprilia, as well as from third-party suppliers, to the Romanian plant. Pfizer aims to raise the capacity of the plant in Cluj-Napoca to 11 million packages in the next few years from three million packages in 2013. The upgrade and the expansion works are to be completed by the end of March 2015, it added.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PFE:GR €23.67 EUR +0.30

PFE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bayer AG €112.01 EUR +5.69
Merck & Co Inc $60.31 USD +0.43
Novartis AG SFr.88.45 CHF -0.45
Roche Holding AG SFr.283.30 CHF +2.50
Procter & Gamble Co/The $84.19 USD +0.03
View Industry Companies
 

Industry Analysis

PFE

Industry Average

Valuation PFE Industry Range
Price/Earnings 19.1x
Price/Sales 3.8x
Price/Book 2.5x
Price/Cash Flow 13.0x
TEV/Sales 2.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PFIZER INC, please visit www.pfizer.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.